Oxalic Acid

Oxalic Acid

SCHEMBL29680569

Cn1ccc2cncnc21.O=C(O)C(=O)O

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

OPRM1SLC6A4

The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.41
MKNK2 Q9HBH9 8/20 0.39
CYP1A2 P05177 6/20 0.38
CYP3A4 P08684 4/20 0.38
TSHR P16473 3/20 0.38
CLK4 Q9HAZ1 1/20 0.38
MKNK1 Q9BUB5 2/20 0.36
CYP2C9 P11712 3/20 0.35
ALDH1A1 P00352 2/20 0.35
HSD17B10 Q99714 2/20 0.35
CYP2C19 P33261 2/20 0.35
USP2 O75604 1/20 0.34
NTRK1 P04629 2/20 0.34
IRAK4 Q9NWZ3 2/20 0.34
LMNA P02545 1/20 0.33
PIK3CB P42338 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256370 0.89 MKNK2 (0.45) MKNK2CYP1A2CYP3A4TSHRCLK4
SCHEMBL30694603 0.89 MKNK2 (0.45) MKNK2CYP1A2CYP3A4TSHRCLK4
SCHEMBL4417290 0.76 MKNK2 (0.41) MKNK2CYP1A2CYP3A4TSHRCLK4
SCHEMBL29665757 0.76 MKNK2 (0.41) MKNK2CYP1A2CYP3A4TSHRCLK4
SCHEMBL30564558 0.75 NOTUM (0.43) NOTUMMKNK2CYP1A2CYP3A4TSHR
SCHEMBL25388631 0.72 MKNK2 (0.38) MKNK2CYP1A2CYP3A4TSHRCLK4
SCHEMBL30564554 0.72 PIK3CB (0.33) NOTUMMKNK2PIK3CB
SCHEMBL30319582 0.71 PARP1 (0.58) MKNK2MKNK1
SCHEMBL31365162 0.71 ENPP3 (0.38) MKNK2MKNK1IRAK4
SCHEMBL30172790 0.71 MKNK2 (0.40) MKNK2CYP3A4TSHRMKNK1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250360134-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INST NAT SANTE RECH MED (FR) 2025-11-27 US claimed
EP-4263539-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE TREATMENT OF INFECTIOUS DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) 2023-10-25 EP claimed
WO-2022129376-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-06-23 WO claimed
US-20250360134-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INST NAT SANTE RECH MED (FR) 2025-11-27 US disclosed
EP-4263539-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE TREATMENT OF INFECTIOUS DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - INSERM (FR) 2023-10-25 EP disclosed
WO-2022129376-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250360134-A1 6-6 OR 5-6 FUSED BICYCLIC COMPOUNDS COMPRISING A PYRI(MI)DINE RING USEFUL IN THE|TREATMENT OF INFECTIOUS DISEASES SARS1, CCR5, INTS6 NOTUM 3526/4885MKNK2 3738/4885CYP1A2 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.